<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="77353">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02001545</url>
  </required_header>
  <id_info>
    <org_study_id>NIS-CBG-XXX-2013/1</org_study_id>
    <nct_id>NCT02001545</nct_id>
  </id_info>
  <brief_title>REal World Information on Cardiovascular Drug Management Patterns in Acute Coronary Syndrome paTients</brief_title>
  <acronym>RE-ACT</acronym>
  <official_title>REal World Information on Cardiovascular Drug Management Patterns in Acute Coronary Syndrome paTients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AstraZeneca</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>AstraZeneca</source>
  <oversight_info>
    <authority>Bulgaria: Bulgarian Drug Agency</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      RE-ACT is a national, multi-centre, observational, prospective, longitudinal cohort study
      which will include patients hospitalized for ACS within 24 hours of symptom onset and who
      have a final diagnosis of ST-segment elevation myocardial infarction (STEMI) or
      non-ST-segment elevation myocardial infarction (NSTEMI). This study aims to describe the
      short-term (at the end of the first month after index event) antithrombotic management
      patterns in a &quot;real-life&quot; setting for patients hospitalized with an acute coronary syndrome.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2014</start_date>
  <completion_date type="Anticipated">September 2014</completion_date>
  <primary_completion_date type="Anticipated">September 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Short-term antithrombotic management patterns (AMPs) in a real-life setting for patients hospitalized with an ACS</measure>
    <time_frame>Baseline</time_frame>
    <safety_issue>No</safety_issue>
    <description>Descriptive statistics will be calculated for this outcome measure using frequency tables (n, frequency and percentage). Antithrombotic management patterns will be grouped taking into account only the different treatment options shown by the descriptive analysis.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Variations in the acute clinical management strategies and AMPs.</measure>
    <time_frame>Baseline</time_frame>
    <safety_issue>No</safety_issue>
    <description>Descriptive statistics will be calculated for this outcome measure using frequency tables (n, frequency and percentage).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Impact of the different AMPs on quality of life at discharge from hospital (using EuroQoL-5D).</measure>
    <time_frame>Baseline</time_frame>
    <safety_issue>No</safety_issue>
    <description>Descriptive statistics will be calculated for this outcome measure using frequency tables (n, mean, median, standard deviation, minimum and maximum)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Impact of the different AMPs on quality of life at the end of the first month after discharge from the hospital (using EuroQoL-5D).</measure>
    <time_frame>At the end of the first month after index event</time_frame>
    <safety_issue>No</safety_issue>
    <description>Descriptive statistics will be calculated for this outcome measure using frequency tables (n, mean, median, standard deviation, minimum and maximum)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Determinants of AMP choices (i.e. patient's characteristics, hospital characteristics, coronary intervention strategies and type of coronary stents used)</measure>
    <time_frame>Baseline</time_frame>
    <safety_issue>No</safety_issue>
    <description>Descriptive statistics will be calculated for this outcome measure using frequency tables (n, frequency and percentage).</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">754</enrollment>
  <condition>Acute Coronary Syndrome</condition>
  <arm_group>
    <arm_group_label>Patients with STEMI and NSTEMI</arm_group_label>
    <description>Patients aged 18 years or older, hospitalized and diagnosed with STEMI (ST-segment elevation myocardial infarction) or NSTEMI (non-ST-segment elevation myocardial infarction) within 24 hours of symptom onset.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients aged 18 years or older, hospitalized and diagnosed with STEMI (ST-segment
        elevation myocardial infarction) or NSTEMI (non-ST-segment elevation myocardial
        infarction) within 24 hours of symptom onset.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Provision of subject informed consent

          -  Patients hospitalized and diagnosed with STEMI or NSTEMI

          -  Hospitalized within 24 hours of onset of symptoms or transferred from another
             hospital within 24 hours of the onset of symptoms

        Exclusion Criteria:

          -  STEMI and NSTEMI precipitated by or as a complication of surgery, trauma, or GI
             bleeding or post-PCI.

          -  STEMI and NSTEMI occurring in patients already hospitalized for other reasons.

          -  Presence of any condition/circumstance which in the opinion of the investigator could
             significantly limit the complete follow up of the patient (e.g. tourist, non-native
             speaker or does not understand the local language, psychiatric disturbances).
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Elina Trendafilova, Ass. Prof. M.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Cardiology Hospital, Sofia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Vasil Velchev, Ass. Prof. M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital St. Anna</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Marina Staneva</last_name>
    <phone>+359 (2) 44 55 000</phone>
    <email>ClinicalTrialTransparency@astrazeneca.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>MHAT Blagoevgrad</name>
      <address>
        <city>Blagoevgrad</city>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Katya Ilieva, M.D.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>SHATC - Cardio center &quot;Pontika&quot;</name>
      <address>
        <city>Burgas</city>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mariana Konteva, M.D.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>MHAT &quot;Proff. Dr. Paraskev Stoyanov&quot;</name>
      <address>
        <city>Lovech</city>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Angel Mitov, M.D.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>MHAT Plovdiv</name>
      <address>
        <city>Plovdiv</city>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ivan Manukov, M.D.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>MHAT &quot;Pulmed&quot; Plovdiv</name>
      <address>
        <city>Plovdiv</city>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>SHATC &quot;Medica Cor&quot;</name>
      <address>
        <city>Ruse</city>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Hristo Popov, M.D.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University hospital &quot;St. Ekaterina&quot;</name>
      <address>
        <city>Sofia</city>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Diana Trendafilova, Ass. Prof. M.D.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>MHAT &quot;Tokuda Hospital Sofia&quot;</name>
      <address>
        <city>Sofia</city>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Valeri Gelev, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Second MHAT-Sofia</name>
      <address>
        <city>Sofia</city>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zlatka Purvanova, M.D.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University hospital &quot;St. Anna&quot;</name>
      <address>
        <city>Sofia</city>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vasil Velchev, Ass. Prof. M.D.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>National Cardiology Hospital</name>
      <address>
        <city>Sofia</city>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elina Trendafilova, Ass. Prof. M.D.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>MHAT Sofiamed</name>
      <address>
        <city>Sofia</city>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Dobri Hazarbasanov, Ass. prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>MHAT &quot;Prof. Dr. Stoyan Kirkovich&quot;</name>
      <address>
        <city>Stara Zagora</city>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Margarit Penev, Ass. Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>MHAT &quot;Sveta Marina&quot;</name>
      <address>
        <city>Varna</city>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Atanas Penev, Ass. Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>MHAT &quot;Hristo Botev&quot;</name>
      <address>
        <city>Vratsa</city>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Petya Yordanova, M.D.</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Bulgaria</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 25, 2014</lastchanged_date>
  <firstreceived_date>November 18, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>acute coronary syndrome, antithrombotic management patterns,quality of life, acute clinical management strategies</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Acute Coronary Syndrome</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Cardiovascular Agents</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
